AI Verdict
VRTX has stronger fundamentals based on our AI analysis.
AMGN vs VRTX Fundamental Comparison
| Metric | AMGN | VRTX |
|---|---|---|
| Revenue | $8.6B | $3.0B |
| Net Income | $1.8B | $1.0B |
| Net Margin | 21.1% | 34.5% |
| ROE | 19.8% | 5.3% |
| ROA | 2.0% | 3.9% |
| Current Ratio | 1.26x | 3.02x |
| Debt/Equity | 6.24x | 0.01x |
| EPS | $3.34 | $4.02 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
AMGN vs VRTX: Frequently Asked Questions
Is AMGN or VRTX the better stock in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), VRTX has stronger fundamentals. AMGN is graded A (79% confidence) while VRTX is graded A (81% confidence). This is not investment advice.
How does AMGN compare to VRTX fundamentally?
AMGEN INC has ROE of 19.8% vs VERTEX PHARMACEUTICALS INC / MA's 5.3%. Net margins are 21.1% vs 34.5% respectively.
Which stock pays higher dividends, AMGN or VRTX?
AMGN has a dividend yield of N/A or no dividend while VRTX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in AMGN or VRTX for long term?
For long-term investing, consider that AMGN has a A grade with 79% confidence, while VRTX has a A grade with 81% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about AMGN vs VRTX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For AMGN vs VRTX, the AI consensus favors VRTX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.